Rationale and experience with combination therapies in multiple sclerosis
β Scribed by Mike Boggild
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 356 KB
- Volume
- 253
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Acute multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). As listed in Table I, the lesions (plaques) are infiltrated first by perivascular and then by parenchymal T lymphocytes with a CD4' over CD8' cell type pre-Address reprint requests to
The rationale for the use of interferon (IFN) in the treatment of multiple sclerosis (MS) is based on its recognized antiviral and irnmunomodulating actions. The pathogenesis of MS is believed to be due to an immunologic response in a genetically predisposed individual, localized within the central